AXS Knowledge Leaders ETF (KNO)

The AXS Knowledge Leaders ETF (KNO) rests on a premise that has grown more relevant each decade: in modern economies, the most durable competitive advantages come not from factories, land, or scale, but from ideas, research, patents, and proprietary expertise. The fund invests in companies and sectors where the real moat — the reason a competitor cannot easily copy them — is something you cannot touch: a brand that commands loyalty, a network of customers and suppliers that is difficult to displace, a library of patents and intellectual property, or a team of researchers and engineers that consistently innovates faster than rivals.

The shift from capital to intellect

For much of the industrial era, a company’s value came from the factories it owned, the raw materials it controlled, the scale of its sales force, and the efficiency of its production. A competitor could build a rival factory, hire workers, and take market share. Competitive advantage was durable only if you could protect it with distribution networks or lock-in contracts. Intellectual property existed but was secondary.

That world has fundamentally shifted. A pharmaceutical company’s value rests largely on its patent portfolio and the skill of its research teams, not on the factories where pills are pressed. A software company is worth billions for code that costs almost nothing to replicate — the value lies in what it does and the difficulty of reimagining it. A brand like Apple or Nike is worth hundreds of billions of dollars not because of the physical plants (which could be sold or replaced) but because consumers believe the brand means quality, innovation, or status. A financial-services company with proprietary trading algorithms, network effects with institutions, or decades of relationship capital cannot be easily copied.

KNO attempts to systematically identify and invest in companies whose moat is primarily intellectual: companies where the sustainable competitive advantage comes from patents, research, brand equity, network effects, data ownership, or specialist expertise. These are companies where the real assets live on the balance sheet as intangible assets — goodwill from acquisitions of small research firms, capitalized R&D, patents and trademarks — and in the minds and habits of customers and partners.

What the fund holds

Because the criterion is abstract — intellectual capital rather than a concrete sector — the fund necessarily holds a diverse set of holdings. Pharmaceutical and biotechnology companies appear because drug patents are the clearest form of knowledge capital. Software companies, where the product is essentially pure intellectual property, dominate a large portion. Luxury brands appear because the brand itself — the intangible association of a name with quality or status — is what customers are paying for. Financial-services companies with proprietary research and trading systems appear. Semiconductor and chipmaking companies, where the designs and the manufacturing expertise are equally important, appear. Even some traditional manufacturing companies show up if the portfolio manager believes their intellectual capital — engineering expertise, design, process innovation — is the real source of competitive advantage.

The holdings are not limited to the United States or to high-tech; the fund is global, and knowledge capital exists everywhere. A German machinery company with a century of specialized engineering expertise, a Japanese pharmaceutical firm with a distinctive pipeline, or a Dutch semiconductor equipment maker with patented processes all fit the brief.

The wager and the risks

The fund makes a simple but powerful bet: that in a modern, developed-world economy, companies whose competitive advantages stem from intellect will outperform those whose advantages stem from capital and scale. Over the very long term, this has proven true — the best-performing stocks of the past several decades have been innovation leaders and brand builders, not commodity producers or scale-dependent manufacturers. The logic is compelling: intellectual property is harder to replicate than a factory, more defensible against competition, and generates higher margins once amortized.

But the bet carries risks. First, intellectual capital is more fragile than it appears. A pharmaceutical company’s value evaporates if its key drug patents expire. A software company’s value crashes if a competitor leapfrogs its technology. Brands can fall out of favor or be challenged by cheaper alternatives. Second, many companies claiming to be “intellectual capital” leaders are actually extracting value from market power or regulatory protection rather than genuine innovation — a distinction that is easy to miss and that can collapse when regulation or competition shifts. Third, the fund is necessarily concentrated in sectors and geographies where knowledge capital thrives (rich, innovative countries and capital-intensive sectors like biotech and software), which can introduce concentration risk. Fourth, a sharp shift in interest rates or investor sentiment against growth and innovation can hurt the fund disproportionately, because these stocks often trade on future potential rather than current dividends or earnings.

Active management and style

Unlike many knowledge-capital themed funds, KNO is actively managed rather than tied to a fixed index. This means the portfolio manager has discretion to choose which companies qualify as true knowledge leaders and which are merely claiming the label. That discretion can add value if the manager is skilled at identifying durable intellectual moats and avoiding value traps that claim to innovate but do not. It also means the fund charges higher fees than a passive index.

How to research the fund

Start with the fund’s fact sheet and most recent holdings. They should tilt heavily toward sectors where intellectual property and expertise dominate — pharmaceuticals, software, semiconductors, financial services, premium brands — rather than commodity producers or traditional capital-intensive industries. Look at the concentration: if the fund is 30% in three mega-cap tech stocks, it is narrower than if it is spread across 50 smaller knowledge leaders. Check the fund manager’s track record and philosophy — does he or she seem to have a coherent thesis about what constitutes knowledge capital, or does the fund feel like an ad-hoc collection of whatever stocks the manager likes?

Research the fund’s performance across different regimes. In low-interest-rate environments where growth is favored, knowledge-capital and innovation funds typically outperform. In rising-rate or value-friendly environments, they can lag. Compare KNO’s returns to a broad global equity index and to other growth-oriented or innovation-focused funds to see whether the manager is genuinely adding value or simply capturing a sector bet that investors could have made directly.

Finally, consider the fund’s risk profile and size of position. Because it concentrates in growth and innovation, it carries higher volatility than a broad market index. If you are using it, ensure it is sized appropriately for your tolerance for drawdowns and your overall portfolio balance.